[go: up one dir, main page]

Zirconium ions up-regulate the BMP/SMAD signaling pathway and promote the proliferation and differentiation of human osteoblasts

PLoS One. 2015 Jan 20;10(1):e0113426. doi: 10.1371/journal.pone.0113426. eCollection 2015.

Abstract

Zirconium (Zr) is an element commonly used in dental and orthopedic implants either as zirconia (ZrO2) or in metal alloys. It can also be incorporated into calcium silicate-based ceramics. However, the effects of in vitro culture of human osteoblasts (HOBs) with soluble ionic forms of Zr have not been determined. In this study, primary culture of human osteoblasts was conducted in the presence of medium containing either ZrCl4 or Zirconium (IV) oxynitrate (ZrO(NO3)2) at concentrations of 0, 5, 50 and 500 µM, and osteoblast proliferation, differentiation and calcium deposition were assessed. Incubation of human osteoblast cultures with Zr ions increased the proliferation of human osteoblasts and also gene expression of genetic markers of osteoblast differentiation. In 21 and 28 day cultures, Zr ions at concentrations of 50 and 500 µM increased the deposition of calcium phosphate. In addition, the gene expression of BMP2 and BMP receptors was increased in response to culture with Zr ions and this was associated with increased phosphorylation of SMAD1/5. Moreover, Noggin suppressed osteogenic gene expression in HOBs co-treated with Zr ions. In conclusion, Zr ions appear able to induce both the proliferation and the differentiation of primary human osteoblasts. This is associated with up-regulation of BMP2 expression and activation of BMP signaling suggesting this action is, at least in part, mediated by BMP signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Morphogenetic Protein 2 / genetics
  • Bone Morphogenetic Protein Receptors / genetics
  • Bone Morphogenetic Proteins / metabolism*
  • Calcification, Physiologic / drug effects
  • Carrier Proteins / metabolism
  • Cell Differentiation
  • Cell Proliferation / drug effects
  • Chlorides / pharmacology*
  • Gene Expression Regulation / drug effects
  • Genetic Markers
  • Humans
  • Osteoblasts / cytology
  • Osteoblasts / drug effects*
  • Osteoblasts / metabolism*
  • Osteogenesis / genetics
  • Signal Transduction / drug effects*
  • Smad Proteins / metabolism*
  • Zirconium / pharmacology*

Substances

  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Carrier Proteins
  • Chlorides
  • Genetic Markers
  • Smad Proteins
  • noggin protein
  • Zirconium
  • Bone Morphogenetic Protein Receptors
  • zirconium chloride

Grants and funding

The work was supported by the following: National Health and Medical Research Council of Australia; Project grant 632654, National Health and Medical Research Council https://www.nhmrc.gov.au; and Rebecca Cooper Medical Research Foundation http://cooperfoundation.org.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.